Patent · US Active

Synthetic Oplophorus luciferases with enhanced light output

US11667950B2 · kind B2 · utility

1Cited by

7References

10Claims

0Family size

Assignee

Promega Corporation · US

Inventors

Lance P. Encell · Fitchburg, US
Mary Hall · Waunakee, US
Paul Otto · Madison, US
Gediminas Vidugiris · Fitchburg, US
Keith V. Wood · Verona, US
Monika G. Wood · Verona, US
Kristopher Zimmerman · Madison, US

Key dates

Filing date	Jun 20, 2022
Grant date	Jun 6, 2023
Priority date	—
Expiry date	Jun 20, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/61
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A polynucleotide encoding a modified luciferase polypeptide. The modified luciferase polypeptide has at least 60% amino acid sequence identity to a wild-type Oplophorus luciferase and includes at least one amino acid substitution at a position corresponding to an amino acid in a wild-type Oplophorus luciferase of SEQ ID NO: 1. The modified luciferase polypeptide has at least one of enhanced luminescence, enhanced signal stability, and enhanced protein stability relative to the wild-type Oplophorus luciferase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.